Standout Papers

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis 2004 2026 2011 2018 1.9k
  1. Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis (2004)
    Jonathan Edwards, L Szczepański et al. New England Journal of Medicine

Immediate Impact

3 by Nobel laureates 22 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
2 intermediate papers

Works of D. Close being referenced

A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis
2017
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout

Author Peers

Author Last Decade Papers Cites
D. Close 1456 796 1166 25 2.9k
Anna Filipowicz‐Sosnowska 1709 785 1063 36 3.3k
R. John Looney 1012 694 1323 25 2.5k
Tim Shaw 1289 632 883 15 2.4k
Michael E. Luggen 1855 400 866 43 2.9k
J. D. Macfarlane 1667 495 859 39 2.9k
Raymond E. Felgar 791 672 1334 38 2.7k
L Szczepański 1622 789 1033 18 3.9k
Carla A. Wijbrandts 1704 612 1082 47 2.9k
Mark C. Totoritis 1223 638 858 15 2.1k
Richard Aranda 1279 352 1234 36 3.1k

All Works

Loading papers...

Rankless by CCL
2026